BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, Mehra MR; working group members. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant 2020;39:418-32. [PMID: 32362393 DOI: 10.1016/j.healun.2020.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kuntzen C, Bagha Z. The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.012] [Reference Citation Analysis]
2 Klapper JA. Commentary: The Field Moves Forward. Semin Thorac Cardiovasc Surg 2021;33:416. [PMID: 32846226 DOI: 10.1053/j.semtcvs.2020.07.010] [Reference Citation Analysis]
3 Prakash K, Aslam S. New updates in the world of hepatitis C virus infected organ transplantation. Curr Opin Organ Transplant 2020;25:364-70. [PMID: 32520787 DOI: 10.1097/MOT.0000000000000785] [Reference Citation Analysis]
4 Woolley AE, Singh SK. The curious phenomenon of early cardiac allograft rejection with hepatitis C‒infected donor heart transplants. J Heart Lung Transplant 2020;39:1208-9. [PMID: 32978057 DOI: 10.1016/j.healun.2020.09.002] [Reference Citation Analysis]
5 Villegas-galaviz J, Anderson E, Guglin M. Clinical outcomes of heart transplantation using hepatitis c-viremic donors: a systematic review with meta-analysis. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.010] [Reference Citation Analysis]
6 Vieira JL, Mehra MR. Heart transplantation candidacy. Curr Opin Organ Transplant 2021;26:69-76. [PMID: 33278151 DOI: 10.1097/MOT.0000000000000828] [Reference Citation Analysis]
7 Lewis TC, Lesko M, Rudym D, Lonze BE, Mangiola M, Natalini JG, Chan JCY, Chang SH, Angel LF. One-year immunologic outcomes of lung transplantation utilizing hepatitis C-viremic donors. Clin Transplant 2022;:e14749. [PMID: 35689815 DOI: 10.1111/ctr.14749] [Reference Citation Analysis]
8 Marcondes-Braga FG, Vieira JL, Souza Neto JD, Calado G, Ayub-Ferreira SM, Bacal F, Clausell N. Emerging Topics in Heart Failure: Contemporaneous Management of Advanced Heart Failure. Arq Bras Cardiol 2020;115:1193-6. [PMID: 33470324 DOI: 10.36660/abc.20201194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Stewart ZA, Shah SA, Rolls JA, Guarrera JV, Kandaswamy R, Axelrod DA. Best practice recommendations for the use of hepatitis C viremic donor organs for hepatitis C virus naïve recipients. Clin Transplant 2021;:e14381. [PMID: 34086371 DOI: 10.1111/ctr.14381] [Reference Citation Analysis]
10 Stehlik J, Mehra MR. Secular changes in organ donor profiles and impact on heart and lung transplantation. J Heart Lung Transplant 2020;39:997-1002. [PMID: 32896477 DOI: 10.1016/j.healun.2020.08.004] [Reference Citation Analysis]
11 Ungerman E, Jayaraman AL, Patel B, Khoche S, Subramanian H, Bartels S, Knight J, Gelzinis TA. The Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2020 Part II: Cardiac Transplantation. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00840-5. [PMID: 34657796 DOI: 10.1053/j.jvca.2021.09.026] [Reference Citation Analysis]
12 Hudson MR, Webb AR, Logan AT, Silverman A, Brueckner AJ. Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct-acting antiviral initiation. Clin Transplant 2021;:e14386. [PMID: 34132438 DOI: 10.1111/ctr.14386] [Reference Citation Analysis]
13 Baran DA, Mohammed A, Macdonald P, Copeland H. Heart Transplant Donor Selection: Recent Insights. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00355-4] [Reference Citation Analysis]
14 Crespo-Leiro MG, Costanzo MR, Gustafsson F, Khush KK, Macdonald PS, Potena L, Stehlik J, Zuckermann A, Mehra MR. Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies. Eur Heart J 2022:ehac204. [PMID: 35441654 DOI: 10.1093/eurheartj/ehac204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cowger JA, Goldstein DJ. An opportunity to begin again. J Heart Lung Transplant 2021:S1053-2498(21)02396-2. [PMID: 34330607 DOI: 10.1016/j.healun.2021.07.003] [Reference Citation Analysis]
16 DeFilippis EM, Khush KK, Farr MA, Fiedler A, Kilic A, Givertz MM. Evolving Characteristics of Heart Transplantation Donors and Recipients: JACC Focus Seminar. J Am Coll Cardiol 2022;79:1108-23. [PMID: 35300823 DOI: 10.1016/j.jacc.2021.11.064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Messika J, Eloy P, Roux A, Hirschi S, Nieves A, Le Pavec J, Sénéchal A, Saint Raymond C, Carlier N, Demant X, Le Borgne A, Tissot A, Debray MP, Beaumont L, Renaud-Picard B, Reynaud-Gaubert M, Mornex JF, Falque L, Boussaud V, Jougon J, Mussot S, Mal H; French Group of Lung Transplantation. COVID-19 in Lung Transplant Recipients. Transplantation 2021;105:177-86. [PMID: 33141808 DOI: 10.1097/TP.0000000000003508] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
18 Lampert BC, Kissling K. Approaches and strategies to manage the hepatitis C virus-positive heart donor. Curr Opin Organ Transplant 2022;27:229-34. [PMID: 35649114 DOI: 10.1097/MOT.0000000000000984] [Reference Citation Analysis]
19 Madan S, Patel SR, Vlismas P, Hemmige V, Saeed O, Goldstein DJ, Jorde UP. Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era. J Heart Lung Transplant 2021:S1053-2498(21)02328-7. [PMID: 34176726 DOI: 10.1016/j.healun.2021.05.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]